ReviewTargeted oncology2020

Lessons to be Learnt from Real-World Studies on Immune-Related Adverse Events with Checkpoint Inhibitors: A Clinical Perspective from Pharmacovigilance.

Emanuel Raschi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.